XPO has been a powerful performer in recent years, and the market is now effectively asking whether the current US$181.95 ...

Are today’s levels properly aligned with the cash that the business is expected to generate in the years ahead, based on a ...

Why Everest Medicines Stock Is Back On Investors’ Radar Everest Medicines (SEHK:1952) just added two experienced mRNA cancer ...

Snap (SNAP) has scheduled a conference call on November 4, 2026 to review its third quarter results, drawing renewed ...

Edgewell Personal Care (EPC) came back into focus after fresh data on its three core segments: Wet Shave, Sun and Skin Care, ...

Samantha David, president of WS Development, discusses creating a different iteration of the "village center" and the ...

Boliden has almost doubled investors' money over the past five years, which puts its current share price under a spotlight.

ChemoMetec has seen a sharp share price swing over recent years, and the question now is whether the current price can be ...

Technoprobe’s fair value estimate has shifted slightly from €41.88 to €42.80, putting fresh focus on how analysts frame ...

Tuya (NYSE: TUYA) outlined a shift toward a profitable SaaS profile, centered on its cloud-agnostic IoT software platform.

Supermarket chain Publix has grown its Southeast footprint with nearly 30 more stores than a year ago, but is closing some ...

Yet the bigger story is not the stock price. It is the problem sitting underneath it. CEO Lisa Su took that problem to Asia, ...